183 related articles for article (PubMed ID: 191524)
1. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
O'Reilly RJ; Chibbaro A; Anger E; Lopez C
J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
[TBL] [Abstract][Full Text] [Related]
2. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
Sheridan JF; Aurelian L
Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
[TBL] [Abstract][Full Text] [Related]
3. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte migration inhibitory factor in HSV infections.
Centifanto YM; Zam ZS; McNeill JI; Kaufman HE
Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):863-8. PubMed ID: 212384
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay.
Lopez C; O'Reilly RJ
J Immunol; 1977 Mar; 118(3):895-902. PubMed ID: 191528
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro.
Sheridan JF; Beck M; Smith CC; Aurelian L
J Immunol; 1987 Feb; 138(4):1234-9. PubMed ID: 3027176
[TBL] [Abstract][Full Text] [Related]
7. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte interferon production and transformation after Herpes simplex infections in humans.
Rasmussen LE; Jordan GW; Stevens DA; Merigan TC
J Immunol; 1974 Feb; 112(2):728-36. PubMed ID: 4360547
[No Abstract] [Full Text] [Related]
9. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immune response to herpes simplex virus: type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection.
Jacobs RP; Aurelian L; Cole GA
J Immunol; 1976 Jun; 116(6):1520-5. PubMed ID: 58037
[TBL] [Abstract][Full Text] [Related]
11. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
12. Cellular immunity and herpesvirus infections in cardiac-transplant patients.
Rand KH; Rasmussen LE; Pollard RB; Arvin A; Merigan TC
N Engl J Med; 1977 Jun; 296(24):1372-7. PubMed ID: 193008
[TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy of recurrent Herpes simplex diseases].
Wassilew SW
Hautarzt; 1979 Jun; 30(6):287-91. PubMed ID: 378899
[TBL] [Abstract][Full Text] [Related]
14. [Specific and unspecific immune stimulation in recurrent herpes simplex].
Raab W
Z Hautkr; 1977 May; 52(10):565-72. PubMed ID: 195407
[TBL] [Abstract][Full Text] [Related]
15. Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes.
Fujibayashi T; Hooks JJ; Notkins AL
J Immunol; 1975 Nov; 115(5):1191-3. PubMed ID: 170341
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immunity in herpetic keratitis measured by leukocyte migration inhibition.
Polack FM; Habash N; Zam ZS; Burdette MG
Ann Ophthalmol; 1982 Sep; 14(9):825-7. PubMed ID: 6295252
[TBL] [Abstract][Full Text] [Related]
17. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
Vestey JP; Norval M; Howie S; Maingay J; Neill WA
Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
[TBL] [Abstract][Full Text] [Related]
18. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.
Donnenberg AD; Bell RB; Aurelian L
Cell Immunol; 1980 Dec; 56(2):526-39. PubMed ID: 6258811
[No Abstract] [Full Text] [Related]
19. Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone.
Leung KN; Nash AA; Sia DY; Wildy P
Immunology; 1984 Dec; 53(4):623-33. PubMed ID: 6209206
[TBL] [Abstract][Full Text] [Related]
20. Induction of cell-mediated immunity in herpes simplex virus keratitis. Kinetics of lymphocyte transformation and the effect of antiviral antibody.
Meyers-Elliott RH; Chitjian PA
Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):920-9. PubMed ID: 6250986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
